Publications

5674 Results

Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane induced neuropathy in women undergoing adjuvant breast cancer therapy

Authors
D Hershman;J Unger;K Crew;L Minasian;C Moinpour;L Hansen;DL Lew;L Fehrenbacher;JL Wade;S Wong;G Hortobagyi;F Meyskens;K Albain
Journal / Conference
Journal of Clinical Oncology 31(20):2627-2633;
Year
2013
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID23733756
PMC
PMC3699727
Study Number(s)
S0715

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating OncotypeDX-guided management for women with breast cancer involving lymph nodes

Authors
S Ramsey;W Barlow;A Gonzalez-Angulo;S Tunis;L Baker;J Crowley;P Deverka;D Veenstra;G Hortobagyi
Journal / Conference
Contemporary Clinical Trials 34(1):1-9;
Year
2013
Research Committee(s)
Breast
PMID
PMID23000081
PMC
PMC3525786
Study Number(s)
S1007

Plasma Epstein-Barr viral DNA as a marker of tumor response in Hodgkin lymphoma

Authors
JA Kanakry;H Li;LL Gellert;MV Lemas;W Hsieh;F Hong;KL Tan;R Gascoyne;LI Gordon;RI Fisher;NL Bartlett;P Stiff;B Cheson;R Advani;L Rimsza;B Kahl;SJ Horning
Journal / Conference
Blood 121(18):3547-3553;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23386127
PMC
PMC3643756
Study Number(s)
E2496

Patient income level and cancer clinical trial participation

Authors
J Unger;DL Hershman;K Albain;CM Moinpour;JA Petersen;K Burg;JJ Crowley
Journal / Conference
Journal of Clinical Oncology 31(5):536-542;
Year
2013
Research Committee(s)
Cancer Care Delivery and Outcomes and Comparative Effectiveness
PMID
PMID23295802
PMC
PMC3565180

The efficacy and tolerability of ABVD and Stanford V in older hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

Authors
AM Evens;F Hong;L Gordon;RI Fisher;P Stiff;T Miller;N Bartlett;J Connors;R Gascoyne;H Wagner;M Gospodarowicz;B Cheson;R Advani;R Hoppe;B Kahl;S Horning
Journal / Conference
British Journal of Haematology 161(1):76-86;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID23356491
PMC
PMC3906856
Study Number(s)
E2496

Implementation of timeline reforms significantly speeds up initiation of NCI-sponsored trials

Authors
JS Abrams;M Mooney;J Zwiebel;G Hortobagyi;S Friedman;S Finnigan;P Schettino;A Denicoff;M Kruhm;M Montello;R Misra;S Ansher;K DiPiazza;E Souhan;L Wickerham;PJ Giantonio;R O'Donnell;DM Sullivan;N Soto;G Fleming;S Prindiville;RA Petryshyn;J Hautala;O Grad;RM Meyer;JC Yao;LH Baker;J Buckner;J Doroshow
Journal / Conference
Journal of the National Cancer Institute 105(13):954-959;
Year
2013
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID23776198
PMC
PMC3699438

Phase II trial of carboplatin, paclitaxel, cetuximab and bevacizumab followed by cetuximab and bevacizumab in advanced non-small cell lung cancer: SWOG 0536

Authors
ES Kim;J Moon;R Herbst;M Redman;S Dakhil;M Velasco;F Hirsch;PC Mack;K Kelly;JV Heymach;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 8(12):1519-1528;
Year
2013
Research Committee(s)
Lung
PMID
PMID24189513
PMC
PMC4072123
Study Number(s)
S0536

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-Rituximab vs CHOP + 131Iodine-Tositumomab

Authors
O Press;J Unger;L Rimsza;J Friedberg;M LeBlanc;M Czuczman;M Kaminski;R Braziel;C Spier;A Gopal;D Maloney;B Cheson;S Dakhil;T Miller;R Fisher
Journal / Conference
Clinical Cancer Research 19(23):6624-32;
Year
2013
Research Committee(s)
Lymphoma
PMID
PMID24130072
PMC
PMC3872052
Study Number(s)
S0016

Significance of FAB subclassification of "acute myeloid leukemia, not otherwise specified" in the 2008 WHO classification: analysis of 5,848 newly diagnosed patients

Authors
RB Walter;M Othus;A Burnett;B Lowenberg;H Kantarjian;GJ Ossenkoppele;RK Hills;K van Montfort;F Ravandi;A Evans;SA Pierce;F Appelbaum;EH Estey
Journal / Conference
Blood 121(13):2424-2431;
Year
2013
Research Committee(s)
Leukemia
PMID
PMID23325837
PMC
PMC3612855
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617, S9918

Intermittent versus continuous androgen deprivation in prostate cancer

Authors
M Hussain;C Tangen;DL Berry;C Higano;ED Crawford;G Liu;G Wilding;S Prescott;S Kanaga Sundaram;EJ Small;NA Dawson;B Donnelly;P Venner;UN Vaishampayan;PL Schellhammer;DI Quinn;D Raghavan;B Ely;C Moinpour;NJ Vogelzang;IM Thompson
Journal / Conference
New England Journal of Medicine, Apr 4; 368(14):1314-1325;
Year
2013
Research Committee(s)
Genitourinary
PMID
PMID23550669
PMC
PMC3682658
Study Number(s)
SWOG-9346